Alnylam Pharmaceuticals
Price & Volume
Stats
See more52W Range | $205.87-$484.21 |
Market Cap | $60.3B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $2.4B |
Revenue Growth (YoY) | 17.3% |
Gross Profit (12 Mos) | $2B |
Diluted EPS | -$2.49 |
News
See moreYahoo Finance • 22 hours ago
Are Investors Undervaluing Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) By 48%?
Yahoo Finance • 2 days ago
Dow Jones Futures: Bullish Market Pause; Palantir, Netflix, Oracle Right At Buy Points
Yahoo Finance • 9 days ago
Alnylam yanks Amvuttra TV ad following FDA letter - report
Yahoo Finance • 9 days ago
Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5%
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,230 |
